Grand View Research

Areas of focus for research sites in 2017

Monday, January 30, 2017

The Pulse on Site Success by Christophe Berthoux

As 2016 came to a close, many of us spent time reflecting and forecasting for the next year. The clinical research industry has continued to experience significant change and 2016 was no exception. We explored many topics, most notably patient-centricity, methods aimed at streamlining processes and proactive ways to handle study startup. These themes will continue to remain industry discussion topics and new site models will set trends moving forward.

[Read More]

Report: API market size worth $239.8B by 2025

Tuesday, January 24, 2017

The global active pharmaceutical ingredients (API) market is expected to reach a value of $239.8 billion by 2025, based on a new report by Grand View Research. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular technologies and high capitalization for development of novel drugs are also estimated to boost growth. 

[Read More]

Study: CRO turnover remains high

Thursday, December 22, 2016

Turnover in the U.S. for clinical monitoring jobs (the function that monitors participants’ health during a clinical trial) at CROs remained high at 25.1% in 2015, almost the same as the previous year’s reported 25.4% (2014). Turnover remained high despite the 7% spike in average salaries for professional positions from 2014 to 2015, according to the 18th annual CRO Industry Global Compensation and Turnover Survey, conducted by HR+Survey Solutions, a specialty compensation consulting and research firm.

[Read More]